Cell-penetrating peptide-mediated subunit vaccine generates a potent immune response and protection against Streptococcus iniae in Japanese flounder (Paralichthys olivaceus)

Veterinary Immunology and Immunopathology

Volumn 167, Issue 3-4, 2015, Pages 96-103

  Sun, Yun ^a,b   Hu, Yong hua ^a  

^a INSTITUTE OF OCEANOLOGY   (China)

^b HAINAN UNIVERSITY   (China)

Author keywords

Cell penetrating peptides; Immune protection; Streptococcus iniae; TAT

Indexed keywords

CD8ALPHA ANTIGEN; CELL PENETRATING PEPTIDE; HYBRID PROTEIN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; INTERLEUKIN 1BETA; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY COMPLEX I ALPHA; MAJOR HISTOCOMPATIBILITY COMPLEX II ALPHA; MYXOVIRUS RESISTANCE PROTEIN; NATURAL KILLER ENHANCING FACTOR; RECOMBINANT ANTENNAPEDIA PROTEIN STREPTOCOCCUS INIAE 10 ANTIGEN; RECOMBINANT STREPTOCOCCUS INIAE 10 ANTIGEN ANTENNAPEDIA HOMEOPROTEIN; RECOMBINANT STREPTOCOCCUS INIAE 10 ANTIGEN TRANSACTIVATOR OF TRANSCRIPTION; RECOMBINANT TRANSACTIVATOR OF TRANSCRIPTION STREPTOCOCCUS INIAE 10 ANTIGEN; STREPTOCOCCUS ANTIGEN; STREPTOCOCCUS INIAE VACCINE; STREPTOCOCCUS VACCINE; SUBUNIT VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTENNAPEDIA PROTEIN; ANTP PROTEIN, DROSOPHILA; BACTERIAL ANTIGEN; BACTERIAL VACCINE; BACTERIUM ANTIBODY; DROSOPHILA PROTEIN; TRANSACTIVATOR PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIGEN PRESENTING CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; HOST CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNOFLUORESCENCE MICROSCOPY; LEUKOCYTE; MACROPHAGE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PARALICHTHYS OLIVACEUS; PROTEIN PURIFICATION; RESPIRATORY BURST; STREPTOCOCCUS INFECTION; STREPTOCOCCUS INIAE; SURVIVAL RATE; UPREGULATION; WESTERN BLOTTING; ANIMAL; BLOOD; FISH DISEASES; FLOUNDER; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; VACCINATION; VETERINARY;

ANIMALS; ANTENNAPEDIA HOMEODOMAIN PROTEIN; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CELL-PENETRATING PEPTIDES; DROSOPHILA PROTEINS; FISH DISEASES; FLOUNDER; GENE EXPRESSION; HUMANS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VACCINATION; VACCINES, SUBUNIT;

EID: 84941994763     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2015.07.008     Document Type: Article

References (62)

1. Amend D.F. Potency testing of fish vaccines. International symposium on fish biologics: serodiagnostics and vaccines. Dev. Biol. Stand. 1981, 49:447-454.
2. Apostolopoulos V., Pouniotis D.S., Maanen P.J., Andriessen R.W., Lodding J., Xing P.X., McKenzie I.F.C., Loveland B.E., Pietersz G.A. Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses. Vaccine 2006, 24:3191-3202.
3. Austin D., Austin B. Characteristics of the Diseases. Bacterial Fish Pathogens: Disease of Farmed and Wild Fish 2008, 18. Springer, Berlin.
4. Brooks N.A., Pouniotis D.S., Sheng K.C., Apostolopoulos V., Pietersz G.A. A membrane penetrating multiple antigen peptide (MAP) incorporating ovalbumin CD8 epitope induces potent immune responses in mice. Biochim. Biophys. Acta 2010, 1798:2286-2295.
5. Brooks N.A., Pouniotis D.S., Tang C., Apostolopoulos V., Pietersz G.A. Cell-penetrating peptides: application in vaccine delivery. Biochim. Biophys. Acta 2010, 1805:25-34.
6. Cashman S.M., Sadowski S.L., Morris D.J., Frederick J., Kumar-Singh R. Intercellular trafficking of adenovirus-delivered HSV VP22 from the retinal pigment epithelium to the photoreceptors - implications for gene therapy. Mol. Ther. 2002, 6:813-823.
7. Chen C., Hu Y.H., Xiao Z.Z., Sun L. SmCCL19, a CC chemokine of turbot Scophthalmus maximus, induces leukocyte trafficking and promotes anti-viral and anti-bacterial defense. Fish Shellfish Immunol. 2013, 35:1677-1682.
8. Cheng S., Hu Y.H., Jiao X., Sun L. Identification and immunoprotective analysis of a Streptococcus iniae subunit vaccine candidate. Vaccine 2010, 28:2636-2641.
9. Cheng S., Zhang W., Zhang M., Sun L. Evaluation of the vaccine potential of a cytotoxic protease and a protective immunogen from a pathogenic Vibrio harveyi strain. Vaccine 2010, 28:1041-1047.
10. Dang W., Sun L. Determination of internal controls for quantitative real time RT-PCR analysis of the effect of Edwardsiella tarda infection on gene expression in turbot (Scophthalmus maximus). Fish Shellfish Immunol. 2011, 30:720-728.
11. Derossi D., Joliot A.H., Chassaing G., Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 1994, 269:10444-10450.
12. Dietz G.P., Valbuena P.C., Dietz B. Application of a blood-brain-barrier penetrating form of GDNF in a mouse model for Parkinson's disease. Brain Res. 2006, 1082:61-66.
13. Dorange F., Mehdaoui S.E., Pichon C., Coursaget P., Vautherot J.F. Marek's disease virus (MDV) homologues of herpes simplex virus type 1 UL49 (VP22) and UL48 (VP16) genes: high-level expression and characterization of MDV-1 VP22 and VP 16. J. Gen. Virol. 2000, 81(Pt. 9):2219-2230.
14. Duchardt F., Fotin-Mleczek M., Schwarz H., Fischer R., Brock R. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 2007, 8:848-866.
15. Eguchi A., Akuta T., Okuyama H., Senda T., Yokoi H., Inokuchi H., Fujita S., Hayakawa T., Takeda K., Hasegawa M., Nakanishi M. Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J. Biol. Chem. 2001, 276:26204-26210.
16. Elliott G., O'Hare P. Intercellular trafficking of VP22-GFP fusion proteins. Gene Ther. 1999, 6:145-151.
17. Fawell S., Seery J., Daikh Y., Moore C., Chen L.L., Pepinsky B., Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:664-668.
18. Foerg C., Merkle H.P. On the biomedical promise of cell penetrating peptides: limits versus prospects. J. Pharm. Sci. 2008, 97:144-162.
19. Frankel A.D., Pabo C. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988, 55:1189-1193.
20. Gait M.J. Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues. Cell. Mol. Life Sci. 2003, 60:844-853.
21. Giannouli C., Brulet J.M., Gesche F., Rappaport J., Burny A., Leo O., Hallez S. Fusion of a tumor associated antigen to HIV-1 Tat improves protein-based immuno-therapy of cancer. Anticancer Res. 2003, 23:3523-3532.
22. Green M., Loewenstein P.M. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 1988, 55:1179-1188.
23. Harms J.S., Ren X., Oliveira S.C., Splitter G.A. Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations. J. Virol. 2000, 74:3301-3312.
24. Hiroshi M., Takashi I., Reiko K., Naotaka S., Shinji S. Polyarginine-mediated protein delivery to dendritic cells presents antigen more efficiently onto MHC Class I and Class II and elicits superior antitumor immunity. J. Invest. Dermatol. 2006, 126:1804-1812.
25. Hu Y.H., Sun B.G., Deng T., Sun L. Molecular characterization of Cynoglossus semilaevis CD28. Fish Shellfish Immunol. 2012, 32:934-938.
26. Jones S.W., Christison R., Bundell K., Voyce C.J., Brockbank S.M., Newham P., Lindsay M.A. Characterisation of cell-penetrating peptide-mediated peptide delivery. Br. J. Pharmacol. 2005, 145:1093-1102.
27. Kilk K. Cell-penetrating Peptides and Bioactive Cargos. Strategies and Mechanisms 2004, 66. Stockholm University, Stockholm.
28. Kim D.T., Mitchell D.J., Brockstedt D.G., Fong L., Nolan G.P., Fathman C.G., Engleman E.G., Rothbard J.B. Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide. J. Immunol. (Baltim., MD: 1950) 1997, 159:1666-1668.
29. Li M.F., Wang C., Sun L. Edwardsiella tarda MliC: a lysozyme inhibitor that participates in pathogenesis in a manner that parallels Ivy. Infect. Immun. 2015, 83:538-590.
30. Li M.F., Zhang B., Li J., Sun L. Sil: a Streptococcus iniae bacteriocin with dual role as an antimicrobial and an immunomodulator that inhibits innate immune response and promotes S. iniae infection. PLOS ONE 2014, 9:e96222.
31. Lindgren M., Hallbrink M., Prochiantz A., Langel U. Cell-penetrating peptides. Trends Pharmacol. Sci. 2000, 21:99-103.
32. Low D.E., Liu E., Fuller J., McGeer A. Streptococcus iniae: an emerging pathogen in the aquaculture industry. Emerging Infections 1999, vol. 3:53-65. ASM Press, Washington, DC.
33. Ma J., Xu J., Guan L., Hu T., Liu Q., Xiao J., Zhang Y. Cell-penetrating peptides mediated protein cross-membrane delivery and its use in bacterial vector vaccine. Fish Shellfish Immunol. 2014, 39:8-16.
34. Michel N., Osen W., Gissmann L., Schumacher T.N.M., Zentgraf H., Muller M. Enhanced immunogenicity of HPV16 E7 fusion proteins in DNA vaccination. Virology 2002, 294:47-59.
35. Mittendorf E.A., Peoples G.E., Singletary S.E. Breast cancer vaccines: promise for the future or pipe dream?. Cancer 2007, 110:1677-1686.
36. Perkins S.D., Hartley M.G., Lukaszewski R.A., Phillpotts R.J., Stevenson F.K., Bennett A.M. VP22 enhances antibody responses from DNA vaccines but not by intracellular spread. Vaccine 2005, 23:1931-1940.
37. Qiu R., Sun B., Li J., Liu X., Sun L. Identification and characterization of a cell surface scavenger receptor cysteine-rich protein of Sciaenops ocellatus: bacterial interaction and its dependence on the conserved structural features of the SRCR domain. Fish Shellfish Immunol. 2013, 34:810-818.
38. Richard J.P., Melikov K., Brooks H., Prevot P., Lebleu B., Chernomordik L.V. Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J. Biol. Chem. 2005, 280:15300-15306.
39. Rittner K., Benavente A., Bompard-Sorlet A., Heitz F., Divita G., Brasseur R., Jacobs E. New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo. Mol. Ther. 2002, 5:104-114.
40. Schwarze S.R., Dowdy S.F. In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol. Sci. 2000, 21:45-48.
41. Schwarze S.R., Ho A., Vocero-Akbani A., Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999, 285:1569-1572.
42. Sethuraman V.A., Bae Y.H. TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. J. Control. Release 2007, 118:216-224.
43. Shelby R.A., Klesius P.H., Shoemaker C.A., Evans J.J. Passive immunization of tilapia. Oreochromis niloticus (L.), with anti-Streptococcus iniae whole sera. J. Fish Dis. 2002, 25:1-6.
44. Sun K., Zhang W.W., Hou J.H., Sun L. Immunoprotective analysis of VhhP2, a Vibrio harveyi vaccine candidate. Vaccine 2009, 27:2733-2740.
45. Sun Y., Hu Y.H., Liu C.S., Sun L. Construction and analysis of an experimental Streptococcus iniae DNA vaccine. Vaccine 2010, 23:3905-3912.
46. Sun Y.Y., Sun L. Pseudomonas fluorescens: iron-responsive proteins and their involvement in host infection. Vet. Microbiol. 2015, 10.1016/j.vetmic.2015.01.020.
47. Thoren P.E., Persson D., Isakson P., Goksor M., Onfelt A., Norden B. Uptake of analogs of penetratin, Tat (48-60) and oligoarginine in live cells. Biochem. Biophys. Res. Commun. 2003, 307:100-107.
48. Tonheim T.C., Bøgwald J., Dalmo R.A. What happens to the DNA vaccine in fish? A review of current knowledge. Fish Shellfish Immunol. 2008, 25:1-18.
49. Torchilin V.P., Levchenko T.S. TAT-liposomes: a novel intracellular drug carrier. Curr. Protein Pept. Sci. 2003, 4:133-140.
50. Tong S., Li H., Miao H.Z. The establishment and partial characterization of a continuous fish cell line FG-9307 from the gill of flounder Paralichthys olivaceus. Aquaculture 1997, 156:327-333.
51. Viehl C.T., Tanaka Y., Chen T., Frey D.M., Tran A., Fleming T.P., Eberlein T.J., Goedegebuure P.S. Tat mammaglobin fusion protein transduced dendritic cells stimulate mammaglobin-specific CD4 and CD8 T cells. Breast Cancer Res. Treat. 2005, 91:271-278.
52. Wadia J.S., Dowdy S.F. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Adv. Drug Deliv. Rev. 2005, 57:579-596.
53. Wadia J.S., Stan R.V., Dowdy S.F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 2004, 10:310-315.
54. Woo T., Chien-Fu K., Jeong H., Won K., Jeremy J., Pei-Jer C., Liangmei H., David A.K.B., Wu T.C. Vaccination with a DNA vaccine encoding herpes simplex virus type 1 VP22 linked to antigen generates long-term antigen-specific CD8-positive memory T cells and protective immunity. Hum. Gene Ther. 2004, 15:167-177.
55. Zhang B.C., Zhang J., Sun L. Streptococcus iniae SF1: complete genome sequence, proteomic profile, and immunoprotective antigens. PLOS ONE 2014, 9:e91324.
56. Zhang Y., Ning J.F., Qu X., Meng X.L., Xu J.P. TAT-mediated oral subunit vaccine against white spot syndrome virus in crayfish. J. Virol. Methods 2012, 181:59-67.
57. Zhang W.W., Sun L. Cloning, characterization, and molecular application of a beta-agarase gene from Vibrio sp. strain V134. Appl. Environ. Microbiol. 2007, 73:2825-2831.
58. Zheng W.J., Sun L. Evaluation of housekeeping genes as references for quantitative real time RT-PCR analysis of gene expression in Japanese flounder (Paralichthys olivaceus). Fish Shellfish Immunol. 2011, 30:638-645.
59. Zhou Z.J., Sun L. CsCTL1, a teleost C-type lectin that promotes antibacterial and antiviral immune defense in a manner that depends on the conserved EPN motif. Dev. Comp. Immunol. 2015, 50:69-77.
60. Zhou Z.X., Sun L. Immune effects of R848: evidences that suggest an essential role of TLR7/8-induced, Myd88- and NF-κB-dependent signaling in the antiviral immunity of Japanese flounder (Paralichthys olivaceus). Dev. Comp. Immunol. 2015, 49:113-120.
61. Zhou Z.X., Zhang B.C., Sun L. Poly(I:C) induces antiviral immune responses in Japanese flounder (Paralichthys olivaceus) that require TLR3 and MDA5 and is negatively regulated by Myd88. PLOS ONE 2014, 9:e112918.
62. Zhou Z.X., Zhang J., Sun L. C7: a CpG oligodeoxynucleotide that induces protective immune response against megalocytivirus in Japanese flounder (Paralichthys olivaceus) via toll-like receptor 9-mediated signaling pathway. Dev. Comp. Immunol. 2014, 44:124-132.